Athena Diagnostics - Testing that Makes a Difference
Test Catalog
SearchBrowse

Enter symptom, disease type, test name or code


SearchBrowse

Use this pull down menu to view all tests offered within a disorder cateogy.

Test Catalog

EPM2A DNA Test #411
Type of Disorder: Epilepsy
Typical Presentation: Progressive myoclonus, myoclonic epilepsy, dementia
Disease(s) tested for: Progressive Myoclonus Epilepsy, Lafora disease
Test Details
Test Code: 411
Profiles that contain this test: Lafora Disease Evaluation , Myoclonus Epilepsy Evaluation
Informed Consent Required: Yes
Medicare ABN Required: Yes
Special Notes: Unless a family member has been confirmed by prior testing, it is recommended that this test be done as part of the Lafora disease Evaluation, #415.
Technical Information
Utility: Detection of sequence variations in the EPM2A gene
Methodology: DNA Sequencing
Reference Value: No sequence variation detected
Patents: 6,825,328, 7,550,571
CPT Coding
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
Stacked CPT Code(s): 83891(1), 83898(4), 83904(4), 83909(4), 83912(1)
Shipping Considerations
Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
Preferred Specimen Requirements
Type: Whole blood
Minimum Volume: 10ml
Collection Tube: Lavender top (EDTA)
Storage Conditions: Do not freeze, refrigerate
Shipping Conditions: Room temperature, avoid freezing
Test Turnaround: 28 days
Canada US